Post-Traumatic Stress Disorder (PTSD) Clinical Trials

Find Post-Traumatic Stress Disorder (PTSD) Clinical Trials Near You

The Effect of Estradiol on the Acquisition and Consolidation of Trauma-Associated Memories

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of the current project is to investigate the impact of 3mg of oral estradiol valerate on the formation of intrusive memories after analog trauma. A well-established stress-film paradigm will be used to induce intrusive symptoms in healthy participants. In a double-blind placebo-controlled study, the impact of oral estradiol on intrusive symptoms during and immediately after exposure to a trauma film will be examined. The primary hypothesis is that exogenous oral estradiol will decrease the number of intrusive memories recorded in the four days following experimental trauma compared with placebo controls. This project will contribute to the current understanding of intrusive memory formation in PTSD and may guide the development of future pharmacological preventions.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• healthy female volunteers

• German on B1 level

Locations
Other Locations
Germany
Charité - Universitätsmedizin Berlin
RECRUITING
Berlin
Contact Information
Primary
Tolou Maslahati, M.Sc.
tolou.maslahati@charite.de
0049 30 450 517 567
Time Frame
Start Date: 2024-08-19
Estimated Completion Date: 2028-02-29
Participants
Target number of participants: 273
Treatments
Experimental: Estradiol before the trauma paradigme
3mg of oral estradiol valerate administered two hours before the trauma film (during acquisition of trauma associated memories)
Experimental: Estradiol after the trauma paradigme
3mg of oral estradiol valerate administered immediately after the trauma film (during consolidation of trauma associated memories)
Placebo_comparator: Placebo before and after the trauma film paradigm
Related Therapeutic Areas
Sponsors
Leads: Charite University, Berlin, Germany

This content was sourced from clinicaltrials.gov